Literature DB >> 22273698

IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.

Katherine M Block1, Neale T Hanke, Erin A Maine, Amanda F Baker.   

Abstract

OBJECTIVES: We investigated the signaling pathways activated in response to interleukin 6 (IL-6) in pancreatic cell lines, with a focus on signal transducer and activator of transcription 3 (STAT3) and proto-oncogene serine/threonine-protein (Pim-1) kinase.
METHODS: Interleukin 6 receptor (IL-6R) expression and IL-6-induced cell signaling was measured by Western blotting in human pancreatic cell lines. Cucurbitacin I was used as a pharmacological tool to investigate the role of STAT3 in Pim-1 activation. Stably overexpressing Pim-1 kinase cell lines were characterized for their response to IL-6 in vitro and for their growth rate as flank tumors in scid mice.
RESULTS: Interleukin 6 receptor was expressed across multiple cancer cell lines. In Panc-1 cells, IL-6 treatment increased expression of phosphorylation of signal transducer and activator of transcription 3 and Pim-1 kinase. Cucurbitacin I treatment alone increased pErk1/2 expression in wild-type and Pim-1-overexpressing cell lines and resulted in exaggerated Pim-1 kinase protein levels in control and IL-6-stimulated cells, suggesting that up-regulation of Pim-1 may be partially STAT3 independent. Pim-1 overexpression did not significantly affect growth rate in vitro or in vivo in Panc-1 or MiaPaCa2 cell lines.
CONCLUSIONS: Interleukin 6 activates STAT3 and stimulates Pim-1 kinase in pancreatic cell line models. The regulation and consequence of Pim-1 expression seems to be highly context dependent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273698      PMCID: PMC3337960          DOI: 10.1097/MPA.0b013e31823cdd10

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  35 in total

Review 1.  A road map for those who don't know JAK-STAT.

Authors:  David S Aaronson; Curt M Horvath
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

2.  Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells.

Authors:  Michele Andreucci; Gaetano Lucisano; Teresa Faga; Bernardo Bertucci; Oscar Tamburrini; Antonio Pisani; Massimo Sabbatini; Salvatore Salzano; Mario Vitale; Giorgio Fuiano; Ashour Michael
Journal:  Toxicol Sci       Date:  2010-10-29       Impact factor: 4.849

3.  Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation.

Authors:  Manuela Willert; Antje Augstein; David M Poitz; Alexander Schmeisser; Ruth H Strasser; Ruediger Christian Braun-Dullaeus
Journal:  Basic Res Cardiol       Date:  2009-08-27       Impact factor: 17.165

4.  Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase.

Authors:  J S Krumenacker; V S Narang; D J Buckley; A R Buckley
Journal:  J Neuroimmunol       Date:  2001-02-15       Impact factor: 3.478

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.

Authors:  Dapeng Xu; Stephen A Allsop; Sam M Witherspoon; Jared L Snider; Jen Jen Yeh; James J Fiordalisi; Catherine D White; Daniel Williams; Adrienne D Cox; Antonio T Baines
Journal:  Carcinogenesis       Date:  2011-01-24       Impact factor: 4.944

7.  Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.

Authors:  Chen Huang; Guang Yang; Tao Jiang; Kejian Huang; Jun Cao; Zhengjun Qiu
Journal:  J Exp Clin Cancer Res       Date:  2010-05-19

8.  Pim-1 plays a pivotal role in hypoxia-induced chemoresistance.

Authors:  J Chen; M Kobayashi; S Darmanin; Y Qiao; C Gully; R Zhao; S C Yeung; M H Lee
Journal:  Oncogene       Date:  2009-06-01       Impact factor: 9.867

9.  Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.

Authors:  Kathleen M Woods Ignatoski; Judah Friedman; June Escara-Wilke; Xiaohua Zhang; Stephanie Daignault; Rodney L Dunn; David C Smith; Evan T Keller
Journal:  J Interferon Cytokine Res       Date:  2009-02       Impact factor: 2.607

10.  Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.

Authors:  Ganchimeg Ishdorj; James B Johnston; Spencer B Gibson
Journal:  BMC Cancer       Date:  2011-06-24       Impact factor: 4.430

View more
  26 in total

1.  Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.

Authors:  Marina Y Zemskova; Jin H Song; Bo Cen; Javier Cerda-Infante; Viviana P Montecinos; Andrew S Kraft
Journal:  Cell Signal       Date:  2014-10-28       Impact factor: 4.315

2.  Pim-1 kinase as cancer drug target: An update.

Authors:  Yernar Tursynbay; Jinfu Zhang; Zhi Li; Tursonjan Tokay; Zhaxybay Zhumadilov; Denglong Wu; Yingqiu Xie
Journal:  Biomed Rep       Date:  2015-12-24

Review 3.  PIM1: a promising target in patients with triple-negative breast cancer.

Authors:  Wen Zhao; RuiYue Qiu; Pan Li; Jin Yang
Journal:  Med Oncol       Date:  2017-07-18       Impact factor: 3.064

4.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.

Authors:  F F Blanco; M Jimbo; J Wulfkuhle; I Gallagher; J Deng; L Enyenihi; N Meisner-Kober; E Londin; I Rigoutsos; J A Sawicki; M V Risbud; A K Witkiewicz; P A McCue; W Jiang; H Rui; C J Yeo; E Petricoin; J M Winter; J R Brody
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

5.  α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model.

Authors:  Bilal Bin Hafeez; Ala Mustafa; Joseph W Fischer; Ashok Singh; Weixiong Zhong; Mohammed Ozair Shekhani; Louise Meske; Thomas Havighurst; KyungMann Kim; Ajit Kumar Verma
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 6.  Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?

Authors:  Katie E O'Sullivan; John V Reynolds; Ciara O'Hanlon; Jacintha N O'Sullivan; Joanne Lysaght
Journal:  J Gastrointest Cancer       Date:  2014-03

7.  Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.

Authors:  Ioannis Pozios; Thomas Knösel; Yue Zhao; Gerald Assmann; Iraklis Pozios; Mario H Müller; Christiane J Bruns; Martin E Kreis; Hendrik Seeliger
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-25       Impact factor: 4.553

Review 8.  Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.

Authors:  A Fucic; A Aghajanyan; Z Culig; N Le Novere
Journal:  Pathol Oncol Res       Date:  2018-09-16       Impact factor: 3.201

9.  Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer.

Authors:  Gang Xin; Yao Chen; Paytsar Topchyan; Moujtaba Y Kasmani; Robert Burns; Peter J Volberding; Xiaopeng Wu; Alexandra Cohn; Yiliang Chen; Chien-Wei Lin; Ping-Chih Ho; Roy Silverstein; Michael B Dwinell; Weiguo Cui
Journal:  Cancer Immunol Res       Date:  2021-02-12       Impact factor: 11.151

10.  Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.

Authors:  Maja Narlik-Grassow; Carmen Blanco-Aparicio; Yolanda Cecilia; Marco Perez; Sandra Muñoz-Galvan; Marta Cañamero; Oliver Renner; Amancio Carnero
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.